(NaturalNews)
(Natural News) Since 2016, pharmaceutical giant AbbVie has generated more than $114 billion in revenue from the sale of its anti-inflammatory drug Humira. That same year, Humira was supposed to go off-patent and become generic – meaning it would have cost a whole lot less for consumers – but because of patent manipulation, AbbVie has been … [Read More…] |
Related posts:
Texas seeks more than $1 BILLION from Planned Parenthood for fraudulent Medicaid claims
The Problem with Mental Health & Gun Violence No One Wants to Talk About
Startups with no revenues, but big plans, take Tel Aviv Stock Exchange by storm
Saudi Arabia Is About To Confiscate $33 Billion From Four Of Its Richest People
Buttigieg: Air Travel System Isn't 'Where It Needs to Be' Going into Labor Day
French police unleash tear gas against migrants in Calais, as mayor calls for army help